Urologix, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ULGX research report →
Companywww.urologix.com
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort.
- CEO
- Bryon Merade
- IPO
- 1996
- Employees
- 61
- HQ
- Minneapolis, MN, US
Price Chart
Valuation
- Market Cap
- $2.18K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.73
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 42.80%
- Op Margin
- -48.68%
- Net Margin
- -53.45%
- ROE
- 232.06%
- ROIC
- -235.46%
Growth & Income
- Revenue
- $14.23M · -14.20%
- Net Income
- $-7,608,000 · -77.26%
- EPS
- $-0.36 · -71.43%
- Op Income
- $-6,930,000
- FCF YoY
- 22.87%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -80.29
- Avg Volume
- 2.19K
Get TickerSpark's AI analysis on ULGX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 19, 14 | EMERY SIDNEY W JR | sell | 10,000 |
| Nov 20, 14 | EMERY SIDNEY W JR | sell | 10,000 |
| Nov 6, 14 | EMERY SIDNEY W JR | other | 45,455 |
| Nov 7, 13 | EMERY SIDNEY W JR | other | 50,000 |
| Nov 16, 12 | EMERY SIDNEY W JR | other | 26,516 |
| Nov 16, 12 | EMERY SIDNEY W JR | other | 10,000 |
| Jun 29, 12 | EMERY SIDNEY W JR | buy | 20,000 |
| Dec 6, 11 | EMERY SIDNEY W JR | buy | 5,000 |
| Dec 2, 11 | EMERY SIDNEY W JR | buy | 100 |
| Dec 2, 11 | EMERY SIDNEY W JR | buy | 4,900 |
Our ULGX Coverage
We haven't published any research on ULGX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ULGX Report →